Data / Form D filings / Fibrocell Science, Inc.
Fibrocell Science, Inc.: Form D filings
Fibrocell Science, Inc., a biotechnology company in Exton, PA, filed 11 Form D notices with the SEC between 2010 and 2018. The latest, on December 20, 2018, reports $900,000 sold of a $900,000 offering to 2 investors.
Find out what Fibrocell Science, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 405 EAGLEVIEW BOULEVARD, Exton, PA, 19341
- Phone
- (484) 713-6000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 357097
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 20, 2018 | New notice | $900,000 | $900,000 | $0 | 2 | Dec 7, 2018 | sec.gov |
| Jul 17, 2018 | New notice | $3,064,216 | $3,064,216 | $0 | 3 | Jul 2, 2018 | sec.gov |
| Jun 13, 2018 | New notice | $5,087,980 | $5,087,980 | $0 | 4 | May 29, 2018 | sec.gov |
| Aug 24, 2016 | New notice | $25,000,000 | $17,625,000 | $7,375,000 | 14 | Aug 9, 2016 | sec.gov |
| Oct 15, 2012 | New notice | $45,000,000 | $45,000,000 | $0 | 114 | Oct 9, 2012 | sec.gov |
| May 18, 2012 | New notice | $12,000,000 | $3,353,000 | $8,647,000 | 63 | May 14, 2012 | sec.gov |
| Aug 18, 2011 | New notice | $22,800,000 | $22,800,000 | $0 | 75 | Aug 3, 2011 | sec.gov |
| Feb 3, 2011 | New notice | $7,800,000 | $4,293,000 | $3,507,000 | 67 | Dec 8, 2010 | sec.gov |
| Aug 4, 2010 | New notice | $2,702,000 | $2,702,000 | $0 | 20 | Jul 19, 2010 | sec.gov |
| Mar 29, 2010 | New notice | $3,807,500 | $3,807,500 | $0 | 23 | Mar 4, 2010 | sec.gov |
| Mar 29, 2010 | New notice | $4,880,093 | $4,880,093 | $0 | 11 | Oct 13, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| DOUGLAS J. SWIRSKY | Director | |
| SEAN D. BUCKLEY | Executive Officer | |
| MARC B. MAZUR | Director | |
| MARCUS E. SMITH | Director | |
| CHRISTINE E. ST.CLARE | Director | |
| JOHN M. MASLOWSKI | Executive Officer, Director | |
| KELVIN D. MOORE | Director | |
| JULIAN P. KIRK | Director |
Other biotechnology companies in Pennsylvania that filed recently
- Traws Pharma, Inc. offering · Nov 5, 2026
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
- Merlin Biotech, Inc. $50,000 · Aug 11, 2026
Every Form D from the week of Dec 17, 2018 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Fibrocell Science, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.